Suppr超能文献

TCL1A 的异常激活促进克隆性造血中的干细胞扩增。

Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.

机构信息

Center for Statistical Genetics, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Nature. 2023 Apr;616(7958):755-763. doi: 10.1038/s41586-023-05806-1. Epub 2023 Apr 12.

Abstract

Mutations in a diverse set of driver genes increase the fitness of haematopoietic stem cells (HSCs), leading to clonal haematopoiesis. These lesions are precursors for blood cancers, but the basis of their fitness advantage remains largely unknown, partly owing to a paucity of large cohorts in which the clonal expansion rate has been assessed by longitudinal sampling. Here, to circumvent this limitation, we developed a method to infer the expansion rate from data from a single time point. We applied this method to 5,071 people with clonal haematopoiesis. A genome-wide association study revealed that a common inherited polymorphism in the TCL1A promoter was associated with a slower expansion rate in clonal haematopoiesis overall, but the effect varied by driver gene. Those carrying this protective allele exhibited markedly reduced growth rates or prevalence of clones with driver mutations in TET2, ASXL1, SF3B1 and SRSF2, but this effect was not seen in clones with driver mutations in DNMT3A. TCL1A was not expressed in normal or DNMT3A-mutated HSCs, but the introduction of mutations in TET2 or ASXL1 led to the expression of TCL1A protein and the expansion of HSCs in vitro. The protective allele restricted TCL1A expression and expansion of mutant HSCs, as did experimental knockdown of TCL1A expression. Forced expression of TCL1A promoted the expansion of human HSCs in vitro and mouse HSCs in vivo. Our results indicate that the fitness advantage of several commonly mutated driver genes in clonal haematopoiesis may be mediated by TCL1A activation.

摘要

多种驱动基因的突变会增加造血干细胞(HSCs)的适应性,导致克隆性造血。这些病变是血液癌症的前体,但它们的适应性优势的基础在很大程度上仍然未知,部分原因是缺乏大规模的队列,这些队列通过纵向采样评估了克隆扩展率。在这里,为了规避这一限制,我们开发了一种从单次采样数据推断扩展率的方法。我们将这种方法应用于 5071 名具有克隆性造血的人群。全基因组关联研究表明,TCL1A 启动子中的一个常见遗传多态性与克隆性造血的总体扩展率较慢有关,但这种影响因驱动基因而异。携带这种保护性等位基因的人,其 TET2、ASXL1、SF3B1 和 SRSF2 驱动突变克隆的生长速度或患病率明显降低,但在 DNMT3A 驱动突变克隆中未观察到这种影响。TCL1A 在正常或 DNMT3A 突变的 HSCs 中不表达,但 TET2 或 ASXL1 突变的引入导致 TCL1A 蛋白的表达和体外 HSCs 的扩增。保护性等位基因限制了 TCL1A 表达和突变 HSCs 的扩增,实验性敲低 TCL1A 表达也是如此。TCL1A 的强制表达促进了体外人 HSCs 和体内小鼠 HSCs 的扩增。我们的结果表明,克隆性造血中几种常见突变驱动基因的适应性优势可能是由 TCL1A 激活介导的。

相似文献

8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Clonal hematopoiesis landscape in frequent blood donors.频繁献血者的克隆性造血格局
Blood. 2025 May 22;145(21):2411-2423. doi: 10.1182/blood.2024027999.

引用本文的文献

本文引用的文献

2
The longitudinal dynamics and natural history of clonal haematopoiesis.克隆性造血的纵向动力学和自然史。
Nature. 2022 Jun;606(7913):335-342. doi: 10.1038/s41586-022-04785-z. Epub 2022 Jun 1.
3
Clonal dynamics of haematopoiesis across the human lifespan.人类生命全程中的造血克隆动力学。
Nature. 2022 Jun;606(7913):343-350. doi: 10.1038/s41586-022-04786-y. Epub 2022 Jun 1.
5
9
Clonal expansion in non-cancer tissues.非癌组织中的克隆扩增。
Nat Rev Cancer. 2021 Apr;21(4):239-256. doi: 10.1038/s41568-021-00335-3. Epub 2021 Feb 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验